Lifeward (NASDAQ:LFWD – Get Free Report) and Flywire (NASDAQ:FLYW – Get Free Report) are both computer and technology companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, institutional ownership, valuation and profitability.
Valuation and Earnings
This table compares Lifeward and Flywire”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Lifeward | $22.03 million | 0.45 | -$19.91 million | ($19.66) | -0.33 |
| Flywire | $677.69 million | 2.99 | $13.50 million | $0.23 | 71.48 |
Analyst Ratings
This is a breakdown of recent recommendations for Lifeward and Flywire, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Lifeward | 1 | 0 | 1 | 0 | 2.00 |
| Flywire | 0 | 6 | 8 | 0 | 2.57 |
Lifeward currently has a consensus target price of $10.00, indicating a potential upside of 53.35%. Flywire has a consensus target price of $18.17, indicating a potential upside of 10.50%. Given Lifeward’s higher possible upside, equities analysts plainly believe Lifeward is more favorable than Flywire.
Profitability
This table compares Lifeward and Flywire’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Lifeward | -123.66% | -213.99% | -106.55% |
| Flywire | 4.45% | 3.78% | 2.61% |
Institutional and Insider Ownership
26.8% of Lifeward shares are owned by institutional investors. Comparatively, 95.9% of Flywire shares are owned by institutional investors. 1.5% of Lifeward shares are owned by insiders. Comparatively, 4.4% of Flywire shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Volatility and Risk
Lifeward has a beta of 0.32, indicating that its share price is 68% less volatile than the S&P 500. Comparatively, Flywire has a beta of 1.3, indicating that its share price is 30% more volatile than the S&P 500.
Summary
Flywire beats Lifeward on 13 of the 14 factors compared between the two stocks.
About Lifeward
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Illit, Israel.
About Flywire
Flywire Corporation, together with its subsidiaries, operates as a payments enablement and software company in the United States and internationally. Its payment platform and network, and vertical-specific software help clients to get paid and help their customers to pay. The company’s platform facilitates payment flows across multiple currencies, payment types, and payment options, as well as provides direct connections to alternative payment methods, such as Alipay, Boleto, PayPal/Venmo, and Trustly. It serves education, healthcare, travel, and business to business organizations. The company was formerly known as peerTransfer Corporation and changed its name to Flywire Corporation in December 2016. Flywire Corporation was incorporated in 2009 and is headquartered in Boston, Massachusetts.
Receive News & Ratings for Lifeward Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lifeward and related companies with MarketBeat.com's FREE daily email newsletter.
